Wells Fargo Downgrades Amrize to Equal-Weight, Lowers Price Target to $44

Wells Fargo analyst Timna Tanners downgrades Amrize (NYSE:AMRZ) from Overweight to Equal-Weight and lowers the price target from $55 to $44.